Tango Therapeutics Sub, Inc

Contributing Author

Recent Articles by Tango Therapeutics Sub, Inc

1 hour	Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 TNGX GlobeNewswire
Oct-23	Tango Therapeutics Announces $225 Million Financing TNGX GlobeNewswire
Oct-23	Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers TNGX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information